re: Ann: Important GSK initiatives to new inf... You can bet GSK wouldn't be sticking their necks out on 60m units a year without a firm market demand in mind so this will definitely translate into sales over the next 12 months. Assuming say A$40 a unit that's over $2 billion in sales and at least A$140m pa in royalties, way beyond Biota's ability to comprehend or cope. Bound to be a takeover offer. Plenty of struggling biotechs would love that kind of revenue stream.
- Forums
- ASX - By Stock
- Ann: Important GSK initiatives to new influenza A
re: Ann: Important GSK initiatives to new inf... You can bet GSK...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online